Future forum “Turning point in biotechnology” at the Federal Ministry of Health

Federal Minister for Health, Karl Lauterbach, invited stakeholders from the biotechnology and pharmaceutical industry to the future forum “Turning point in biotechnology: gene therapies, tumor vaccines, antibody-drug combinations” on 21 November. BIO Deutschland sent a letter to the Federal Minister in advance, asking him to take a closer look at the biotechnology industry and its small and medium-sized enterprises in this context. With its business models, it spans the entire spectrum of the industrial healthcare ecosystem. In addition to BIO Deutschland, its members BioSpring and Miltenyi Biotec also took part in the exchange with their CEOs Sylva Wojczewski and Stefan Miltenyi.